A coalition of 20 state attorneys general has raised concerns about the American Medical Association's (AMA) stance on puberty blockers for children, citing inconsistencies in their position compared to their recent opposition to gender-related surgeries. The coalition, led by Alabama Attorney General Steve Marshall, commended the AMA for recognizing a lack of clear evidence to support gender-related surgeries in minors, advocating that such procedures should be reserved for adulthood. However, the group argues that the evidence supporting the use of puberty blockers and cross-sex hormones is equally insufficient.

In their letter to AMA CEO Dr. John J. Whyte, the attorneys general expressed their concern over the apparent double standard in the AMA's positions on these medical interventions for minors experiencing gender dysphoria. They stated, "The quality of evidence is the same as it is for surgeries," which raises questions about the safety and efficacy of puberty blockers in treating young patients. This pushback from state officials indicates a growing skepticism and scrutiny regarding the medical treatment options available to children, particularly in light of evolving social and legal discussions surrounding gender identity.

The implications of this coalition's letter extend beyond the AMA's internal policies, potentially affecting how medical professionals and institutions approach treatments for young individuals facing gender dysphoria. With states increasingly examining and challenging medical practices related to youth gender transitions, this could lead to a broader national conversation on the ethics and science behind such treatments, potentially influencing legislative and regulatory decisions in the future.